Literature DB >> 8142220

Oxidative damage of red blood cells in haemolytic uraemic syndrome.

S Túri1, I Németh, I Vargha, B Matkovics.   

Abstract

Changes in red blood cell (RBC) lipid peroxidation [measured by malonyl dialdehyde (MDA) concentration], glutathione (GSH) metabolism, antioxidant enzyme activities (catalase, superoxide dismutase, glutathione peroxidase) and haemoglobin (Hb) metabolites (metHb, carboxy Hb) were studied in six children with post-enteropathic (D+) haemolytic uraemic syndrome (HUS) and ten controls. The in vitro effect of hydrogen peroxide [acetylphenylhydrazine (APH) test] on GSH and Hb metabolism was also investigated. MDA levels were significantly higher and the antioxidant enzyme activities were lower in HUS patients than in the controls (P < 0.01). The oxidised glutathione concentration was significantly higher in the patients than in the control children (26.3 +/- 12.6 vs. 10.9 +/- 1.8 nmol/g Hb. Percentage values of carboxy Hb and metHb were also higher in HUS (P < 0.01). Incubation of RBC with APH induced a more pronounced decrease in the concentration of GSH (P < 0.001) and a significant increase (P < 0.01) in the level of metHb and carboxy Hb in the HUS patients. This suggests that there is reduced RBC GSH stability in HUS. Utilisation of GSH and antioxidant enzymes leads to increased Hb oxidation and haemolysis. The oxidative damage may have an important role in the pathogenesis of haemolytic anaemia in HUS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8142220     DOI: 10.1007/bf00868253

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  32 in total

1.  The glutathione instability of drug-sensitive red cells; a new method for the in vitro detection of drug sensitivity.

Authors:  E BEUTLER
Journal:  J Lab Clin Med       Date:  1957-01

2.  Neutrophil elastases and haemolytic uraemic syndrome.

Authors:  D Milford; C M Taylor; F Rafaat; E Halloran; J Dawes
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

3.  Serum lipoperoxidation products in an infant with hemolytic-uremic syndrome.

Authors:  R E Brown; S L Alade; J A Knight; B J Evans
Journal:  Clin Chem       Date:  1988-11       Impact factor: 8.327

4.  Oxidative state of glutathione in arterial and venous red blood cells and plasma of rabbit.

Authors:  C Costagliola; M Menzione; L Romano
Journal:  Eur J Haematol       Date:  1987-04       Impact factor: 2.997

5.  Endothelial damage and platelet thrombosis associated with PUFA-rich, vitamin E deficient diet fed to pig.

Authors:  I Nafstad
Journal:  Thromb Res       Date:  1974-08       Impact factor: 3.944

6.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent.

Authors:  J Sedlak; R H Lindsay
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

7.  Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome.

Authors:  K D Forsyth; A C Simpson; M M Fitzpatrick; T M Barratt; R J Levinsky
Journal:  Lancet       Date:  1989-08-19       Impact factor: 79.321

8.  Disturbances of prostacyclin metabolism in children with hemolytic-uremic syndrome and in first degree relatives.

Authors:  S Túri; T J Beattie; J J Belch; A V Murphy
Journal:  Clin Nephrol       Date:  1986-04       Impact factor: 0.975

9.  Vitamin E treatment of haemolytic uraemic syndrome.

Authors:  H R Powell; D A McCredie; C M Taylor; J R Burke; R G Walker
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

10.  Further evidence of lipid peroxidation in post-enteropathic haemolytic-uraemic syndrome.

Authors:  R D Situnayake; B J Crump; D I Thurnham; C M Taylor
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

View more
  6 in total

Review 1.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

2.  Endogenous glucocorticoids modulate neutrophil function in a murine model of haemolytic uraemic syndrome.

Authors:  S A Gómez; G C Fernández; G Camerano; G Dran; F A Rosa; P Barrionuevo; M A Isturiz; M S Palermo
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

Review 3.  Haemolytic uraemic syndrome.

Authors:  W L Robson
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.022

4.  Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin.

Authors:  Masahiro Ikeda; Shuichi Ito; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2004-03-09       Impact factor: 3.714

5.  Impact of placental Plasmodium falciparum malaria on the profile of some oxidative stress biomarkers in women living in Yaoundé, Cameroon.

Authors:  Rosette Megnekou; Jean Claude Djontu; Jude Daiga Bigoga; Fabrice Mbah Medou; Sandrine Tenou; Abel Lissom
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

6.  Action of shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cells.

Authors:  María M Amaral; Flavia Sacerdoti; Carolina Jancic; Horacio A Repetto; Adrienne W Paton; James C Paton; Cristina Ibarra
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.